Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial

Atrial fibrillation (AF) is a common clinically significant cardiac arrhythmia. This phase 3 randomized, double-blind, placebo-controlled trial assessed the efficacy and safety of vernakalant hydrochloride for the pharmacological conversion of AF to sinus rhythm in patients with recent-onset (>3...

Descripción completa

Detalles Bibliográficos
Autores principales: Beatch, Gregory N., Bhirangi, Kiran, Juul-Moller, Steen, Rustige, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295492/
https://www.ncbi.nlm.nih.gov/pubmed/27828791
http://dx.doi.org/10.1097/FJC.0000000000000445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295492/
https://www.ncbi.nlm.nih.gov/pubmed/27828791
http://dx.doi.org/10.1097/FJC.0000000000000445

Ejemplares similares